MARY YOUNGBLOOD: Open Payments
NPI 1063086452 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 43 payments from 23 companies in 2025. Trend: 2023 $153 · 2024 $1,200 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $137 |
| Daiichi Sankyo Inc. | 4 | $110 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| Incyte Corporation | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Janssen Biotech, Inc. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
Products named: Enhertu, Vyloy, KISQALI, LIBTAYO, TAGRISSO, JAKAFI, GILOTRIF, MONOFERRIC.
Industry payments across TN — which companies pay providers there.
